Moo Hyun Kim1, Yongdae Yoon2, Chang Wan Kim1, Jun-Won Lee3, Bhupendra Regmi2, Saher Fatima2, Moon Young Kim2,3, Soon Koo Baik2,3, Pil Young Jung1,*, Young Woo Eom2,*
BIOCELL, Vol.50, No.6, 2026, DOI:10.32604/biocell.2026.076364
- 09 June 2026
Abstract Background: Although transforming growth factor-β (TGF-β) drives hepatic stellate cell activation and fibrogenesis, the mechanisms by which 12-O-tetradecanoylphorbol-13-acetate (TPA) modulates these processes in TGF-β1-activated hepatic stellate cells remain to be determined. Therefore, we investigated whether TPA alleviates fibrosis in TGF-β1-treated hepatic stellate cells and regulates both canonical and non-canonical pathways. Further, we assessed whether inhibitors of these pathways similarly affect proliferation and fibrosis in LX-2 cells. Methods: LX-2 hepatic stellate cells were used as the experimental model. Cells were treated with TPA, TGF-β, or TGF-β plus TPA, and Yes-associated protein (YAP) and protein kinase B (PKB;… More >